Blar i Institutt for klinisk og molekylær medisin på utgivelsesdato
Viser treff 21-40 av 2190
-
Fatigue in cancer treatment - assessment, course and etiology
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:138, Doctoral thesis, 2007)Aims. The major aims of the present work were to increase the understanding of cancer related fatigue with respect to assessment methodology, frequency and possible etiology. The validity of two fatigue instruments was ... -
In vitro interactions between medicinal drugs and herbs on Cytochrome P-450 metabolism and P-glycoprotein transport
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:256, Doctoral thesis, 2007)Omsetningen av naturlegemidler og kosttilskudd har økt dramatisk de siste årene, og en økende aksept for urtebruk tilsier at forbruket fortsatt vil øke. Samtidig bruk av naturlegemidler/urter og legemidler forekommer ofte. ... -
Impact of dietary fat quantity and quality in type 2 diabetes with emphasis on marine n-3 fatty acids
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:83, Doctoral thesis, 2007)Doktoravhandlingen bygger på tre kliniske studier av personer med type 2 diabetes. Artikkel 1. Hensikten var å undersøke effekter av en 3-dagers intervensjon med fettfattig kost. Blodsukker, insulinfølsomhet, fettstoffer ... -
Invasive properties of cancer - a treatment target?: In vitro studies in human prostate cancer cell lines
(Doktoravhandlinger ved NTNU, 1503-8181; 2006:215, Doctoral thesis, 2007) -
Age-specific prevalence of the metabolic syndrome defined by the international diabetes federation and the National Cholesterol Education Program: The Norwegian HUNT 2 study
(Journal article; Peer reviewed, 2007)Background The 2005 International Diabetes Federation (IDF) definition of the metabolic syndrome was designed to be useful worldwide, but to date few prevalence studies have used that definition in European populations. ... -
Quality or equality? The Norwegian experience with medical monopolies
(Journal article; Peer reviewed, 2007)Background: In order to maintain both quality and efficiency of health services in a small country with a scattered population, Norway established a monopoly system for 38 highly specialized medical services. The ... -
Using death certificate data to study place of death in 9 European countries: opportunities and weaknesses
(Journal article; Peer reviewed, 2007)Background: Systematic and reliable epidemiological information at population level, preferably cross-national, is needed for an adequate planning of (end-of-life) health care policies, e.g. concerning place of death, ... -
Changes in BMI-distribution from 1966-69 to 1995-97 in adolescents. The Young-HUNT study, Norway
(Journal article; Peer reviewed, 2007)Background: The aim of this study was to explore changes in the BMI-distribution over time among Norwegian adolescents. Methods: Height and weight were measured in standardised ways and BMI computed in 6774 adolescents ... -
Fetal and perinatal implications of anomalies in the gastrointestinal tract and the abdominal wall
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:113, Doctoral thesis, 2007)Studien tar for seg tilstandene gastroschise og omfalocele, som er forskjellige former for bukveggsdefekter samt utviklingsavvik som gir forsnevringer på ulike nivå i fordøyelseskanalen: spiserør (øsofagusobstruksjon), ... -
Post-term pregnancy
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:242, Doctoral thesis, 2007)Overtidig svangerskap er å betrakte som et risikosvangerskap. Studier har vist at det ved overtid er økt risiko for død i mors mage og i nyfødtperioden. I mange land settes derfor fødselen i gang en uke etter at terminen ... -
Intestinal injury and recovery after ishemia - An experimental study on restitution of the surface epithelium, intestinal permeability, and release of biomarkers from the mucosa
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:212, Doctoral thesis, 2007) -
Role of enteropathogenic Escherichia coli in childhood diarrhoea in Norway
(Doktoravhandlinger ved NTNU, 1503-8181; 2007:260, Doctoral thesis, 2007)Background Diarrhoeal diseases are among the leading causes of illness and death among children in developing countries, and do also cause considerable morbidity in industrialized countries. Enteropathogenic E. coli (EPEC), ... -
Helse- og miljørisikovurdering av genmodifisert soyalinje BPS-CV127-9 BASF Plant Science GmbH (EFSA/GMO/NL/2009/64). 1.innspillsrunde
(VKM Report;, Research report, 2007) -
UTTALELSE OM PIONEER HI-BRED/MYCOGEN SEEDS GENMODIFISERTE MAIS 59122x1507xNK603 (EFSA/GMO/UK/2005/21)
(VKM Report;, Research report, 2007) -
UTTALELSE OM PIONEER HI-BRED/MYCOGEN SEEDS GENMODIFISERT MAIS 1507x59122 (EFSA/GMO/NL/2005/15)
(VKM Report;, Research report, 2007) -
Genmodifisert maislinje MON810. Uttalelse fra Faggruppe for genmodifiserte organismer i Vitenskapskomiteen for mattrygghet 09.11.07
(VKM Report;, Research report, 2007) -
Helse- og miljørisikovurdering genmodifisert mais MON 89034 x 1507 x NK603 fra Monsanto og Dow AgroSciences LLC (EFSA/GMO/NL/2009/65). 1.innspillsrunde
(VKM Report;, Research report, 2007) -
Improved benchmarks for computational motif discovery
(Journal article; Peer reviewed, 2007-06-08)Background An important step in annotation of sequenced genomes is the identification of transcription factor binding sites. More than a hundred different computational methods have been proposed, and it is difficult ... -
CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
(Journal article; Peer reviewed, 2008)Background: Chemoresistance is the main obstacle to cure in most malignant diseases. Anthracyclines are among the main drugs used for breast cancer therapy and in many other malignant conditions. Single parameter analysis ...